Duopharma Biotech Berhad (KLSE:DPHARMA)

Market Cap	1.33B
Revenue (ttm)	883.47M
Net Income (ttm)	73.01M
Shares Out	961.94M
EPS (ttm)	0.08
PE Ratio	18.19
Forward PE	14.20
Dividend	0.03 (2.17%)
Ex-Dividend Date	Mar 5, 2025

Volume	423,700
Average Volume	1,388,155
Open	1.380
Previous Close	1.380
Day's Range	1.360 - 1.380
52-Week Range	1.070 - 1.460
Beta	0.83
RSI	64.79
Earnings Date	May 16, 2025

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides ...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,957
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2024, Duopharma Biotech Berhad's revenue was 813.70 million, an increase of 15.46% compared to the previous year's 704.73 million. Earnings were 62.65 million, an increase of 19.00%.